Update on sales, page-113

We'd need evidence covid is still leading to more sales before we can say if something would reduce sales.

The Remdesivir result is ok but still needs support from a control study. Other actions I think will continue to have a much more significant impact on ICUs. Complacency from okish treatment could even lead to numbers staying up.

I don't think they can manufacture it in large enough quantities yet to use outside critical cases. Though that could change rapidly and hospitals of course look ahead when buying equipment.